Unfortunately no news or hints regarding 3D printing involvement or injection moulding manufacture. Also despite the company predictions of rising revenue and falling costs, the quarterly reveals falling customer receipts (- 52%) and rising research costs (+9%) and rising staff costs (+6.5%) as well as another CR due before end of CY24.
Enough for me to leave AVR on the watch list, waiting for a more suitable entry, until there's some news or trading improves.
Ann: Quarterly Activities/Appendix 4C Cash Flow Report, page-9
Add AVR (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$18.30 |
Change
0.300(1.67%) |
Mkt cap ! $351.7M | |||
| Open | High | Low | Value | Volume |
| $18.25 | $18.30 | $18.01 | $12.33K | 679 |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 300 | $18.09 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $18.30 | 247 | 2 |
View Market Depth
| Last trade - 14.56pm 04/07/2024 (20 minute delay) ? |
| AVR (ASX) Chart |